Live Breaking News & Updates on Arnatar Therapeutics

Stay updated with breaking news from Arnatar therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biotech startup Arnatar raises $50m Series A round to build China presence

Founded in 2022, Arnatar specialises in antisense drug discovery and development. ....

United States , San Diego , Xuehai Liang , Yanfeng Wang , Transfar Group , Merck Co , Valliance Capital , Ionis Pharmaceuticals , Legend Holdings , Arnatar Therapeutics , Eight Roads , Huajin Capital , Gaorong Capital , Jifeng Ventures , New Alliance Capital , Yijing Capital , Apricot Capital ,